Sinovac has already shipped some 380 mn doses, more than AstraZeneca and second only to Pfizer, worldwide. But it still hasn’t published any data in an academic journal.
Indonesia tracked 25,374 health workers in Jakarta for 28 days after receiving their second dose. Health Minister Budi Gunadi said 94% of them had been vaccinated.
Demand is expected to rise if WHO authorises China’s Sinovac & Sinopharm vaccines, allowing developing countries in Asia, Africa & Latin America to access them through Covax.
Vastly different efficacy rates in 4 clinical trial sites raised concerns over whether Sinovac, that’s key to vaccine drives in some of the world's hotspots, will be effective.
The vaccine was found to be about 65% effective against Covid in late stage-trials in the city of Bandung. The emergency use approval is the first for Sinovac’s shot outside of China.
The protection rate, confirmed by Sao Paulo state officials, was derived from Sinovac’s most advanced final-phase trials in Brazil involving about 13,000 participants.
The crisis also puts DGCA’s vacancies in the eye of the storm. Naidu told the Rajya Sabha in July this year that 190 out of 410 DGCA vacancies would be filled this year.
Data shows re-alignment in India’s exports, with Tamil Nadu & Telangana posting strong growth in 2024-25 as traditional heavyweights Gujarat & Maharashtra see declines. Gujarat still leads, though.
Of the total package, $649 million will be utilised for additional hardware, software, and support services, and the remaining for Major Defence Equipment (MDE).
Don’t blame misfortune. This is colossal incompetence and insensitivity. So bad, heads would have rolled even in the old PSU-era Indian Airlines and Air India.
COMMENTS